Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
asthma
Pharma
FTC blasts Teva for 'improper' inhaler patents
After filing a challenge against more than 100 patents in the FDA’s Orange Book, the Federal Trade Commission has singled out Teva in an amicus brief.
Fraiser Kansteiner
Mar 25, 2024 10:04am
AstraZeneca steps up to show Fasenra helping patients step out
Mar 25, 2024 9:56am
GSK sets $35 out-of-pocket price cap for its inhalers in the US
Mar 21, 2024 11:45am
AstraZeneca enlists Walter the Dino to paint rivals as outdated
Mar 21, 2024 7:12am
AstraZeneca caps out-of-pocket inhaler costs at $35 in the US
Mar 18, 2024 11:02am
Boehringer cuts out-of-pocket inhaler prices to $35 in US
Mar 7, 2024 11:10am